Results 31 to 40 of about 96,811 (318)

Drug-eluting stent in diabetes [PDF]

Sao Paulo Medical Journal, 2007
Long-term evaluation of cardiovascular risk among diabetic patients has shown that the incidence of death due to myocardial infarction among these patients is 20%, whereas among nondiabetic patients it is only 3.5%. Such observations haveled to classifying diabetes as a risk that is equivalent to establi shed coronary artery disease.
Lemos Júnior, Hernani Pinto de, Atallah, Álvaro Nagib, Gomes, Walter José   +2 more
openaire   +4 more sources

Biodegradable Cable-Tie Rapamycin-eluting Stents

Scientific Reports, 2017
“Cable-tie” type biodegradable stents with drug-eluting nanofiber were developed to treat rabbit denuded arteries in this study. Biodegradable stents were fabricated using poly-L-lactide film following being cut and rolled into a cable-tie type stent ...
Cheng-Hung Lee, Ming-Jer Hsieh, Shang-Hung Chang, Chang-Lin Chiang, Ching-Lung Fan, Shih-Jung Liu, Wei-Jan Chen, Chao-Jan Wang, Ming-Yi Hsu, Kuo-Chun Hung, Chung-Chuan Chou, Po-Cheng Chang   +11 more
doaj   +1 more source

Revascularisation versus medical treatment in patients with stable coronary artery disease: network meta-analysis. [PDF]

, 2014
peer reviewedOBJECTIVE: To investigate whether revascularisation improves prognosis compared with medical treatment among patients with stable coronary artery disease.
Alfonso, Fernando, Clemmensen, Peter M, Collet, Jean-Philippe, Cremer, Jochen, da Costa, Bruno R, daCosta, Bruno R, Di Nisio, Marcello, Falk, Volkmar, Filippatos, Gerasimos, Hamm, Christian, Head, Stuart, Juni, Peter, Jüni, Peter, Kappetein, Arie Pieter, Kastrati, Adnan, Knuuti, Juhani, Kolh, Philippe, Landmesser, Ulf, Laufer, Günther, Maione, Ausilia, Neumann, Franz-Joseph, Richter, Dimitri, Rutjes, Anne Wilhelmina, Schauerte, Patrick, Siletta, Maria G, Silletta, Maria G, Sousa Uva, Miguel, Stefanini, Giulio G, Stortecky, Stefan, Taggart, David P, Torracca, Lucia, Valgimigli, Marco, Wijns, William, Windecker, Stephan, Witkowski, Adam   +34 more
core   +4 more sources

Restenosis of Drug-Eluting Stents.

Circulation. Cardiovascular Interventions, 2019
Despite on-going evolution and iteration of drug-eluting stent (DES) technology, the prevalence of in-stent restenosis (ISR) remains relatively unchanged, encompassing ≈10% of percutaneous coronary interventions.
Evan Shlofmitz, M. Iantorno, R. Waksman
semanticscholar   +1 more source

Emotions and scope effects in the monetary valuation of health [PDF]

, 2018
JEL classifications: H41 H51 I11 I18 I31This study presents evidence on the role of emotions in the monetary evaluation of health technologies, namely, drug-eluting stents (DES) in our case.
Araña, Jorge, Avilés Blanco, Maria V., Brey, Raúl, Pinto Prades, Jose Luis   +3 more
core   +1 more source

Single versus two-stent strategies for coronary bifurcation lesions: a systematic review and meta-analysis of randomized trials with long-term follow-up [PDF]

, 2018
Background: The majority of coronary bifurcation lesions are treated with a provisional single‐stent strategy rather than an up‐front 2‐stent strategy.
Berry, Colin, Collison, Damien, Corcoran, David, Ford, Thomas J., Hennigan, Barry, Hildick-Smith, David, McCartney, Peter, McEntegart, Margaret, Oldroyd, Keith G.   +8 more
core   +1 more source

Newer-Generation Ultrathin Strut Drug-Eluting Stents Versus Older Second-Generation Thicker Strut Drug-Eluting Stents for Coronary Artery Disease: Meta-Analysis of Randomized Trials

Circulation, 2018
Background: Contemporary second-generation drug-eluting stents (DES) have superior efficacy and safety in comparison with early-generation stents in patients undergoing percutaneous coronary intervention, in part, related to their thinner struts. Whether
S. Bangalore, Bora Toklu, Neil S. Patel, F. Feit, G. Stone   +4 more
semanticscholar   +1 more source

Comparative efficacy of drug-eluting balloon and drug-eluting stent for treatment of in-stent restenosis: a systematic review and meta-analysis

Journal of the Pakistan Medical Association
Objective: To compare the efficacy of drug-eluting stents and drug-eluting balloons in treating in-stent restenosis. Method: The systematic review was conducted from January to February 2022, and comprised literature search on PubMed, ProQuest ...
Tinanda Tarigan, Daniel Sukmadja, Kaka Citta Prasiddha, Rizkan Triatmaja   +3 more
doaj   +1 more source

The stenting strategy of drug-eluting stents for coronary artery disease in patients on dialysis

SAGE Open Medicine, 2014
Background: Reports regarding the relationship between the length and diameter of implanted drug-eluting stents and clinical and angiographic outcomes in dialysis patients are limited.
Hiroshi Fujita, Kenya Nasu, Mitsuyasu Terashima, Tsuyoshi Ito, Tomomitsu Tani, Takahiko Suzuki, Nobuyuki Ohte   +6 more
doaj   +1 more source

Reestenose tardia associada à fratura de stent Cypher Reestenosis tardía asociada a fractura de stent Cypher Late restenosis related to Cypher stent fracture

Arquivos Brasileiros de Cardiologia, 2009
Os stents farmacológicos representam um importante avanço na terapêutica da doença aterosclerótica coronariana. Recentemente tem sido descrita a fratura de stents farmacológicos, associada à reestenose e trombose.
Michel Pereira Cadore, Henrique Pereira Abelin, Romualdo Bolzani dos Santos, Paulo Ricardo Avancini Caramori   +3 more
doaj   +1 more source